Key Financial Inc’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.7K Hold
225
﹤0.01% 711
2025
Q4
$21.9K Hold
225
﹤0.01% 701
2025
Q3
$15.8K Hold
225
﹤0.01% 765
2025
Q2
$13.5K Hold
225
﹤0.01% 775
2025
Q1
$11.8K Hold
225
﹤0.01% 782
2024
Q4
$12.4K Hold
225
﹤0.01% 774
2024
Q3
$11.3K Hold
225
﹤0.01% 762
2024
Q2
$9.89K Hold
225
﹤0.01% 781
2024
Q1
$9.9K Hold
225
﹤0.01% 763
2023
Q4
$10.7K Hold
225
﹤0.01% 719
2023
Q3
$9.98K Hold
225
﹤0.01% 711
2023
Q2
$10.7K Buy
+225
New +$10.1K ﹤0.01% 703

Other funds holding IRMD

Key Financial Inc's IRMD Position: Q1 2026 in Review

Key Financial Inc held its iRadimed (IRMD) position steady in Q1 2026 at 225 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #711.

Key Financial Inc first reported a position in IRMD in Q2 2023 and has held it in 12 quarters since. The position peaked at $21.9K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Key Financial Inc held 225 shares of iRadimed worth $21.7K as of Q1 2026.
  • Key Financial Inc left its iRadimed share count unchanged in Q1 2026.
  • iRadimed made up ﹤0.01% of Key Financial Inc's portfolio in Q1 2026, its #711 holding.
  • Key Financial Inc first reported a position in iRadimed in Q2 2023 and has held it in 12 quarters since.
  • Key Financial Inc's iRadimed position peaked at $21.9K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Key Financial Inc's 13F filing for Q1 2026, filed 24 Apr 2026.